Study Results Demonstrate Greater Potential of New Diabetes Therapy Beyond Glucose Control
Meta-Analysis Presented at the CDA/CSEM Professional Conference and Annual Meetings Provides Insight into GLP-1 Therapy Advances
MISSISSAUGA, ON, Nov. 8 /PRNewswire/ -
To view this Social Media Release, please enter the following address in your web browser.
SOURCE Novo Nordisk Canada Inc.
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.